Novo Nordisk's valuation now more attractive: Bernstein By Investing.com

Published on 15 Jan 2025 on Investing.com

Bernstein analysts highlighted a more attractive valuation for Novo Nordisk (NYSE:NVO) following...

Read the rest of the article

Start tracking your investments with Statfolio

Friday's share price fall saw Novo Nordisk be overtaken by luxury goods firm LVMH (MC.PA) as...

Yahoo Finance UK 3 hours ago

We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese...

Insider Monkey · via Yahoo Finance 19 Jan 2025

It hasn't been a great period for investors in Novo Nordisk (NYSE: NVO) despite its ongoing statu...

Motley Fool · via Yahoo Finance 18 Jan 2025

As of 11 a.m. ET, shares of Novo Nordisk (NVO -5.19%) are down 4.2%, and Hims & Hers Health (HIMS...

The Motley Fool 17 Jan 2025

The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiatio...

Yahoo Finance · via AOL 17 Jan 2025

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in...

247wallst.com 15 Jan 2025

Bernstein analysts highlighted a more attractive valuation for Novo Nordisk (NYSE:NVO) following...

Investing.com 15 Jan 2025

Bad news for Eli Lilly (NYSE: LLY) stock dragged down shares of rival companies in the market for...

Motley Fool · via Yahoo Finance 14 Jan 2025

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soare...

Insider Monkey · via Yahoo Finance 14 Jan 2025

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in...

247wallst.com 14 Jan 2025